Literature DB >> 21792630

Design of a fragment library that maximally represents available chemical space.

M N Schulz1, J Landström, K Bright, R E Hubbard.   

Abstract

Cheminformatics protocols have been developed and assessed that identify a small set of fragments which can represent the compounds in a chemical library for use in fragment-based ligand discovery. Six different methods have been implemented and tested on Input Libraries of compounds from three suppliers. The resulting Fragment Sets have been characterised on the basis of computed physico-chemical properties and their similarity to the Input Libraries. A method that iteratively identifies fragments with the maximum number of similar compounds in the Input Library (Nearest Neighbours) produces the most diverse library. This approach could increase the success of experimental ligand discovery projects, by providing fragments that can be progressed rapidly to larger compounds through access to available similar compounds (known as SAR by Catalog).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21792630     DOI: 10.1007/s10822-011-9461-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  31 in total

Review 1.  Structural biology in fragment-based drug design.

Authors:  Christopher W Murray; Tom L Blundell
Journal:  Curr Opin Struct Biol       Date:  2010-05-12       Impact factor: 6.809

Review 2.  SAR by NMR: putting the pieces together.

Authors:  Philip J Hajduk
Journal:  Mol Interv       Date:  2006-10

Review 3.  Fragment-based lead discovery: a chemical update.

Authors:  Daniel A Erlanson
Journal:  Curr Opin Biotechnol       Date:  2006-11-03       Impact factor: 9.740

4.  Lessons for fragment library design: analysis of output from multiple screening campaigns.

Authors:  I-Jen Chen; Roderick E Hubbard
Journal:  J Comput Aided Mol Des       Date:  2009-06-03       Impact factor: 3.686

Review 5.  Fragment-based discovery of inhibitors of protein kinase B.

Authors:  Thomas G Davies; Steven J Woodhead; Ian Collins
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

6.  Lead generation and examples opinion regarding how to follow up hits.

Authors:  Masaya Orita; Kazuki Ohno; Masaichi Warizaya; Yasushi Amano; Tatsuya Niimi
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

7.  Experiences in fragment-based lead discovery.

Authors:  Roderick E Hubbard; James B Murray
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

8.  From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.

Authors:  Anthony M Giannetti
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

9.  Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics.

Authors:  Wan F Lau; Jane M Withka; David Hepworth; Thomas V Magee; Yuhua J Du; Gregory A Bakken; Michael D Miller; Zachary S Hendsch; Venkataraman Thanabal; Steve A Kolodziej; Li Xing; Qiyue Hu; Lakshmi S Narasimhan; Robert Love; Maura E Charlton; Samantha Hughes; Willem P van Hoorn; James E Mills
Journal:  J Comput Aided Mol Des       Date:  2011-05-21       Impact factor: 3.686

10.  Discovering high-affinity ligands for proteins: SAR by NMR.

Authors:  S B Shuker; P J Hajduk; R P Meadows; S W Fesik
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

View more
  7 in total

1.  Evaluation of docking performance in a blinded virtual screening of fragment-like trypsin inhibitors.

Authors:  Georgiana Surpateanu; Bogdan I Iorga
Journal:  J Comput Aided Mol Des       Date:  2011-12-17       Impact factor: 3.686

2.  Discovery of selective small-molecule activators of a bacterial glycoside hydrolase.

Authors:  John F Darby; Jens Landström; Christian Roth; Yuan He; Gideon J Davies; Roderick E Hubbard
Journal:  Angew Chem Int Ed Engl       Date:  2014-10-07       Impact factor: 15.336

3.  Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay.

Authors:  Helton J Wiggers; Josmar R Rocha; William B Fernandes; Renata Sesti-Costa; Zumira A Carneiro; Juliana Cheleski; Albérico B F da Silva; Luiz Juliano; Maria H S Cezari; João S Silva; James H McKerrow; Carlos A Montanari
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

Review 4.  Use of Natural Products in Leishmaniasis Chemotherapy: An Overview.

Authors:  Luiza F O Gervazoni; Gabrielle B Barcellos; Taiana Ferreira-Paes; Elmo E Almeida-Amaral
Journal:  Front Chem       Date:  2020-11-23       Impact factor: 5.221

Review 5.  In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery.

Authors:  Lauro Ribeiro de Souza Neto; José Teófilo Moreira-Filho; Bruno Junior Neves; Rocío Lucía Beatriz Riveros Maidana; Ana Carolina Ramos Guimarães; Nicholas Furnham; Carolina Horta Andrade; Floriano Paes Silva
Journal:  Front Chem       Date:  2020-02-18       Impact factor: 5.221

6.  Fragment-derived modulators of an industrial β-glucosidase.

Authors:  Eleni Makraki; John F Darby; Marta G Carneiro; James D Firth; Alex Heyam; Eiso Ab; Peter O'Brien; Gregg Siegal; Roderick E Hubbard
Journal:  Biochem J       Date:  2020-11-27       Impact factor: 3.857

7.  Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.

Authors:  Alexander Metz; Jan Wollenhaupt; Steffen Glöckner; Niki Messini; Simon Huber; Tatjana Barthel; Ahmed Merabet; Hans Dieter Gerber; Andreas Heine; Gerhard Klebe; Manfred S Weiss
Journal:  Acta Crystallogr D Struct Biol       Date:  2021-08-23       Impact factor: 7.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.